Small Molecules & Biologics
Small Molecules & Biologics
We’ll now move on to the second stage of this partnership, which will be focused on continuing to improve the production process
"We’re excited to achieve the first milestone of our collaboration with Merck and continue our work to improve biologic manufacturing production. It’s very meaningful when our team can drive impactful and technically innovative work like this, especially when we’re working shoulder-to-shoulder with counterparts like the team at Merck. As we go into the next phase of this project, we’ll continue to deploy the strain engineering, high-throughput screening and process development capabilities, as well as the assets and know-how that make Ginkgo a unique and powerful partner to top pharmaceutical companies." — Jason Kelly, CEO and co-founder, Ginkgo Bioworks
Posted by Jason Kelly